Panion & Bf Biotech Future Growth
Future criteria checks 0/6
Panion & Bf Biotech is forecast to grow revenue at 7.5% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 59.1% |
| Revenue growth rate | 7.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 Oct 2024 |
Recent future growth updates
Recent updates
Is Panion & Bf Biotech (TWSE:1760) A Risky Investment?
Aug 13
Here's Why Panion & Bf Biotech (TPE:1760) Has A Meaningful Debt Burden
Apr 07Is Panion & Bf Biotech Inc. (TPE:1760) A Strong Dividend Stock?
Mar 03Introducing Panion & Bf Biotech (TPE:1760), A Stock That Climbed 47% In The Last Three Years
Feb 04
Are Panion & Bf Biotech Inc.'s (TPE:1760) Mixed Financials Driving The Negative Sentiment?
Jan 09Panion & Bf Biotech (TPE:1760) Has A Somewhat Strained Balance Sheet
Dec 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,229 | N/A | N/A | 34 | 1 |
| 12/31/2024 | 2,063 | 137 | 162 | 406 | 1 |
| 9/30/2024 | 2,036 | 121 | 190 | 380 | N/A |
| 6/30/2024 | 2,009 | 101 | 93 | 295 | N/A |
| 3/31/2024 | 1,973 | 98 | 74 | 285 | N/A |
| 12/31/2023 | 1,882 | 77 | -4 | 177 | N/A |
| 9/30/2023 | 1,821 | -49 | -76 | 139 | N/A |
| 6/30/2023 | 2,008 | 22 | 63 | 280 | N/A |
| 3/31/2023 | 2,353 | 165 | 195 | 407 | N/A |
| 12/31/2022 | 2,399 | 182 | 291 | 490 | N/A |
| 9/30/2022 | 2,396 | 274 | 261 | 440 | N/A |
| 6/30/2022 | 2,263 | 256 | 250 | 408 | N/A |
| 3/31/2022 | 1,982 | 169 | 225 | 386 | N/A |
| 12/31/2021 | 1,901 | 104 | 231 | 401 | N/A |
| 9/30/2021 | 1,950 | 147 | 135 | 301 | N/A |
| 6/30/2021 | 1,807 | 84 | 61 | 223 | N/A |
| 3/31/2021 | 1,602 | 2 | -64 | 64 | N/A |
| 12/31/2020 | 1,569 | 28 | -116 | -15 | N/A |
| 9/30/2020 | 1,521 | 47 | 39 | 113 | N/A |
| 6/30/2020 | 1,485 | 68 | 20 | 113 | N/A |
| 3/31/2020 | 1,558 | 122 | -71 | 24 | N/A |
| 12/31/2019 | 1,574 | 161 | -21 | 91 | N/A |
| 9/30/2019 | 1,573 | 196 | -58 | 58 | N/A |
| 6/30/2019 | 1,555 | 200 | -52 | 31 | N/A |
| 3/31/2019 | 1,503 | 194 | 29 | 88 | N/A |
| 12/31/2018 | 1,409 | 159 | 39 | 79 | N/A |
| 9/30/2018 | 1,289 | 82 | 17 | 43 | N/A |
| 6/30/2018 | 1,272 | 86 | N/A | 76 | N/A |
| 3/31/2018 | 1,193 | 61 | N/A | 110 | N/A |
| 12/31/2017 | 1,212 | 91 | N/A | 114 | N/A |
| 9/30/2017 | 1,206 | 142 | N/A | 179 | N/A |
| 6/30/2017 | 1,140 | 131 | N/A | 211 | N/A |
| 3/31/2017 | 1,100 | 120 | N/A | 193 | N/A |
| 12/31/2016 | 1,049 | 90 | N/A | 177 | N/A |
| 9/30/2016 | 1,030 | 54 | N/A | 93 | N/A |
| 6/30/2016 | 1,101 | 70 | N/A | 58 | N/A |
| 3/31/2016 | 1,153 | 71 | N/A | 58 | N/A |
| 12/31/2015 | 1,205 | 73 | N/A | 58 | N/A |
| 9/30/2015 | 1,169 | 59 | N/A | 68 | N/A |
| 6/30/2015 | 1,133 | 46 | N/A | 79 | N/A |
| 3/31/2015 | 1,074 | 47 | N/A | 77 | N/A |
| 12/31/2014 | 1,014 | 48 | N/A | 76 | N/A |
| 9/30/2014 | 973 | 39 | N/A | 106 | N/A |
| 6/30/2014 | 932 | 30 | N/A | 137 | N/A |
| 3/31/2014 | 895 | 24 | N/A | 111 | N/A |
| 12/31/2013 | 857 | 18 | N/A | 86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1760's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if 1760's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 1760's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1760's revenue (7.5% per year) is forecast to grow slower than the TW market (12.7% per year).
High Growth Revenue: 1760's revenue (7.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1760's Return on Equity is forecast to be high in 3 years time